2,4,6-tribromo-3-hydroxybenzoic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 151915 |
SCHEMBL ID | 124390 |
MeSH ID | M0128471 |
Synonym |
---|
benzoic acid, 2,4,6-tribromo-3-hydroxy- |
2,4,6-tribromo-3-hydroxybenzoic acid, 97% |
inchi=1/c7h3br3o3/c8-2-1-3(9)6(11)5(10)4(2)7(12)13/h1,11h,(h,12,13 |
2,4,6-tribromo-3-hydroxybenzoic acid |
14348-40-4 |
tbhba |
T1764 |
A808075 |
3-hydroxy-2,4,6-tribromobenzoic acid , |
2,4,6-thba |
FT-0615800 |
AKOS015856233 |
HY-15929 |
SCHEMBL124390 |
AC-24639 |
mfcd00055557 |
DTXSID20162437 |
AS-62665 |
SY032570 |
AC9208 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |